KLDO Insider Trading Activity and SEC Form 4 Filings
KLDO insider trading summary
No open-market insider purchases or sales of Kaleido Biosciences, Inc. (KLDO) have been reported on SEC Form 4 in the past 12 months.
Latest KLDO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 8, 2021 | Flagship Ventures Fund IV, L.P. | 10% Owner | Buy | $824K (71,667 @ $11.50) |
| Feb 8, 2021 | Flagship Ventures Fund IV General Partner LLC | 10% Owner | Buy | $824K (71,666 @ $11.50) |
| Feb 8, 2021 | Flagship Ventures Fund IV, L.P. | 10% Owner | Buy | $824K (71,666 @ $11.50) |
| Feb 8, 2021 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy | $824K (71,666 @ $11.50) |
| Feb 8, 2021 | Flagship Ventures Opportunities Fund I, L.P. | 10% Owner | Buy | $824K (71,666 @ $11.50) |
| Feb 8, 2021 | Nutritional Health LTP Fund General Partner LLC | 10% Owner | Buy | $824K (71,666 @ $11.50) |
| Feb 8, 2021 | Nutritional Health LTP Fund, L.P. | 10% Owner | Buy | $824K (71,666 @ $11.50) |
| Feb 8, 2021 | Noubar Afeyan | 10% Owner | Buy | $824K (71,666 @ $11.50) |
| Feb 8, 2021 | Flagship Ventures Fund IV General Partner LLC | 10% Owner | Buy | $824K (71,667 @ $11.50) |
| Feb 8, 2021 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy | $824K (71,667 @ $11.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.